ResearcherFred Hutch Cancer CenterActive in the last 2 years
Seetharaman Balasenthil
Matched on ORCID iD 0000-0001-9168-8362; OpenAlex author ID A5059533792. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 37
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 7
- Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-29548-4↗
- Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery Study. Co-author DOI 10.1158/1078-0432.ccr-25-4061↗
- Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in Prediagnostic Samples. Co-author DOI 10.1016/j.gastha.2024.08.002↗
- Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes. Co-author DOI 10.1016/j.cca.2023.117567↗
- A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djw341↗
- Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens. Co-author DOI 10.1371/journal.pone.0139049↗
- A migration signature and plasma biomarker panel for pancreatic adenocarcinoma. Co-author DOI 10.1158/1940-6207.capr-10-0025↗
Closest collaborators
The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Subrata Sen · 7 shared papers, 2011–2026 · strength 0.93
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Paper Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal … DOI 10.1016/j.cca.2023.117567↗
- Ann McNeill Killary · 7 shared papers, 2011–2026 · strength 0.93
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Paper Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal … DOI 10.1016/j.cca.2023.117567↗
- Suyu Liu · 4 shared papers, 2017–2026 · strength 0.63
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Paper Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal … DOI 10.1016/j.cca.2023.117567↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Anirban Maitra · 3 shared papers, 2023–2026 · strength 0.58
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal … DOI 10.1016/j.cca.2023.117567↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Randall E. Brand · 4 shared papers, 2015–2026 · strength 0.50
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Ye Hu · 2 shared papers, 2024–2026 · strength 0.41
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Warapen Treekitkarnmongkol · 2 shared papers, 2024–2026 · strength 0.41
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Eugene Jon Koay · 2 shared papers, 2024–2026 · strength 0.41
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Paul D. Lampe · 2 shared papers, 2024–2026 · strength 0.41
- Paper Machine learning-based multimodal biomarkers enable accurate diagnosis and early detection of pancreatic ductal adenoca… DOI 10.1038/s41598-025-29548-4↗
- Paper Blood-Based microRNA Biomarker Signature of Early-Stage Pancreatic Ductal Adenocarcinoma With Lead-Time Trajectory in P… DOI 10.1016/j.gastha.2024.08.002↗
- Sudhir Srivastava · 3 shared papers, 2015–2026 · strength 0.32
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Paper A Plasma Biomarker Panel to Identify Surgically Resectable Early-Stage Pancreatic Cancer. DOI 10.1093/jnci/djw341↗
- Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
- Michael Anthony Hollingsworth · 2 shared papers, 2015–2026 · strength 0.26
- Paper Pancreatic Cancer Detection Consortium Biomarker Bakeoff: A Phase II Blinded Biomarker Validation and Panel Discovery S… DOI 10.1158/1078-0432.ccr-25-4061↗
- Paper Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specim… DOI 10.1371/journal.pone.0139049↗
- Tsung-Hung Yao · 1 shared paper, 2026 · strength 0.24
- Nagireddy Putluri · 1 shared paper, 2026 · strength 0.24
- Suprateek Kundu · 1 shared paper, 2026 · strength 0.24
- Lynette M. Smith · 1 shared paper, 2026 · strength 0.23
- Masataka Hayashi · 1 shared paper, 2026 · strength 0.23
- Brianna M. Krusen · 1 shared paper, 2026 · strength 0.23
- Ann L. Oberg · 1 shared paper, 2026 · strength 0.23
- Michael Goggins · 1 shared paper, 2026 · strength 0.23
- Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.23
- Surinder K. Batra · 1 shared paper, 2026 · strength 0.23
- Shounak Majumder · 1 shared paper, 2026 · strength 0.23
- Maneesh Jain · 1 shared paper, 2026 · strength 0.23
- Kenneth S. Zaret · 1 shared paper, 2026 · strength 0.23
- Suresh T. Chari · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.